Beli & Jual Diastika Biotekindo Tbk. - CHEK Hari Ini
Quarterly
Yearly
Income Statement
Revenue
Net Profit
Net Loss
Profit margin %
Q4
’24
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Revenue | Rp201,31 M | +30.05% |
| Cost of Revenue | Rp124,17 M | +31.99% |
| Gross Profit | Rp77,14 M | +27.04% |
| General Expenses, Depreciation, Interest | Rp53,99 M | +37.64% |
| Operating Profit | Rp23,15 M | +7.72% |
| Other Income | -Rp5,83 M | +163.99% |
| EBT | Rp18,4 M | -4.57% |
| Taxes | -Rp4,38 M | -206.56% |
| Net Income | Rp14,02 M | -7.59% |
Balance Sheet
Assets
Liabilities
Debt to Asset %
Q4
’24
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| Total Assets | Rp259,53 M | +118.44% |
| Total Liabilities | Rp48,45 M | +89.5% |
| Total Equity | Rp211,08 M | +126.38% |
| Total Liabilities & Total Equity | Rp259,53 M | +118.44% |
Cash Flow
Operating
Investing
Finance
Net CF
Q4
’24
Q2
’25
Q3
’25
Q4
’25
| Item | Q4 2025 | Y/Y Change |
| CF from Operations | Rp43,15 M | -430.85% |
| CF from Investment | Rp27,27 M | +79.38% |
| CF from Financing | Rp121,43 M | -78954.06% |
| Net Cash Flow | Rp51,01 M | -2305.33% |